Cubist Pharmaceuticals, Inc. misses by $0.23, misses on revenue

|By:, SA News Editor

Cubist Pharmaceuticals, Inc. (CBST): Q1 EPS of $0.10 misses by $0.23.

Revenue of $261.23M (+13.6% Y/Y) misses by $24.01M.